Antihypertensive treatment with ACEI/ARB of patients with COVID-19 complicated by hypertension

被引：54
|
作者：
Li, Gang [1 ]
Hu, Rui [2 ]
Zhang, Xuejiao [1 ]
机构：
[1] Hebei Gen Hosp, Geriatr Inst, Cardiol Div, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Med Univ, Gen Clin Lab, Hosp 2, Shijiazhuang, Hebei, Peoples R China
来源：
HYPERTENSION RESEARCH | 2020年 / 43卷 / 06期
基金：
中国国家自然科学基金;
关键词：
ANGIOTENSIN-CONVERTING ENZYME; SARS CORONAVIRUS; ACE2; RECEPTOR; EXPRESSION; PNEUMONIA;
D O I：
10.1038/s41440-020-0433-1
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：588 / 590
页数：3
相关论文
共 50 条
  • [21] Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19
    Seiji Hamada
    Tomoharu Suzuki
    Yasuharu Tokuda
    Kiyosu Taniguchi
    Kenji Shibuya
    Scientific Reports, 13 (1)
  • [22] Safety of ACEi and ARB in COVID-19 management: A retrospective analysis
    Kumar, Sabina
    Nikravesh, Mastaneh
    Chukwuemeka, Umeh
    Randazzo, Michael
    Flores, Peter
    Choday, Prithi
    Raja, Ajith
    Aseri, Mahendra
    Shivang, Shah
    Chaudhuri, Sumanta
    Barve, Pranav
    CLINICAL CARDIOLOGY, 2022, 45 (07) : 759 - 766
  • [23] In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension
    Yuan, Yuan
    Liu, Dan
    Zeng, Shaoqing
    Wang, Siyuan
    Xu, Sen
    Wang, Ya
    Yu, Ruidi
    Gao, Yue
    Li, Huayi
    Feng, Xinxia
    Zhou, Ning
    Zhao, Chunxia
    Gao, Qinglei
    JOURNAL OF INFECTION, 2020, 81 (05) : 829 - 832
  • [24] Pharmacological rationale for antihypertensive drug choice on COVID-19-affected patients: ACEI/ARB might not increase their susceptibility
    Zhao, Hong-Jin
    Yang, Xiao-Mei
    Wang, Ai-Hong
    Li, Yan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (21) : 12879 - 12881
  • [25] ACEI, ARB and Diuretic Usage: Implications on Survival in Patients With COVID-19 Admitted to Mather Hospital
    Badar, F.
    Ashraf, A.
    Usman, S.
    Iftikhar, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [26] Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19
    Khan, Sikandar Hayat
    Zaidi, Sabeen Khurshid
    DRUGS & THERAPY PERSPECTIVES, 2020, 36 (08) : 347 - 350
  • [27] Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19
    Sikandar Hayat Khan
    Sabeen Khurshid Zaidi
    Drugs & Therapy Perspectives, 2020, 36 : 347 - 350
  • [28] ACEI/ARB在COVID-19治疗中应用的思考
    王仲
    方奕鹏
    郭喆
    柴彦
    实用休克杂志(中英文), 2020, 4 (02) : 80 - 83+95
  • [29] ACEi reduces hypertension-induced hyperinflammation in COVID-19
    Lim, Gregory B.
    NATURE REVIEWS CARDIOLOGY, 2021, 18 (04) : 231 - 231
  • [30] Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension
    Zhang, Zhe
    Wu, Shengyong
    Wang, Zhiyong
    Wang, Yue
    Chen, Hui
    Wu, Cheng
    Xiong, Lize
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
12345